ADIAL PHARMACEUTICALS, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA, 22901
Mailing Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA, 22901
Phone
434-422-9800
Fiscal Year End
1231
EIN
800667150
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 10-K Annual financial report | March 5, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 8-K Current report of material events | February 24, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 18, 2026 | View on SEC |
| 8-K Current report of material events | February 4, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | January 6, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| 424B5 Prospectus supplement | December 19, 2025 | View on SEC |
| S-3 Shelf registration for future offerings | December 12, 2025 | View on SEC |
Annual Reports
10-K
March 5, 2026
- Developing AD04 for Alcohol Use Disorder (AUD) in genetically-defined patients, addressing a significant unmet medical need.
- AD04 utilizes a low-dose version of ondansetron, an active ingredient already approved for other conditions, potentially streamlining development.
Material Events
8-K
Other
February 24, 2026
High Impact
- Successfully regained Nasdaq compliance, removing immediate delisting threat.
- Maintains liquidity and visibility for investors on a major exchange.
8-K
Other
February 4, 2026
High Impact
- Preserves Nasdaq listing, which is vital for credibility and visibility.
- Ensures liquidity and facilitates future funding for clinical trials and operations.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.